The Small C-terminal Domain Phosphatase 1 Inhibits Cancer Cell Migration and Invasion by Dephosphorylating Ser(P)68-Twist1 to Accelerate Twist1 Protein Degradation

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2016 Mar 16

PMID 26975371

Citations 19

Authors

Tong Sun

Junjiang Fu

Tao Shen

Xia Lin

Lan Liao

Xin-Hua Feng

Jianming Xu

Affiliations

Soon will be listed here.

Abstract

Twist1 is a basic helix-loop-helix transcription factor that strongly promotes epithelial-to-mesenchymal transition, migration, invasion, and metastasis of cancer cells. The MAPK-phosphorylated Twist1 on its serine 68 (Ser(P)(68)-Twist1) has a significantly enhanced stability and function to drive cancer cell invasion and metastasis. However, the phosphatase that dephosphorylates Ser(P)(68)-Twist1 and destabilizes Twist1 has not been identified and characterized. In this study, we screened a serine/threonine phosphatase cDNA expression library in HEK293T cells with ectopically coexpressed Twist1. We found that the small C-terminal domain phosphatase 1 (SCP1) specifically dephosphorylates Ser(P)(68)-Twist1 in both cell-free reactions and living cells. SCP1 uses its amino acid residues 43-63 to interact with the N terminus of Twist1. Increased SCP1 expression in cells decreased Ser(P)(68)-Twist1 and total Twist1 proteins, whereas knockdown of SCP1 increased Ser(P)(68)-Twist1 and total Twist1 proteins. Furthermore, the levels of SCP1 are negatively correlated with Twist1 protein levels in several cancer cell lines. SCP1-dephosphorylated Twist1 undergoes fast degradation via the ubiquitin-proteasome pathway. Importantly, an increase in SCP1 expression in breast cancer cells with either endogenous or ectopically expressed Twist1 largely inhibits the Twist1-induced epithelial-to-mesenchymal transition phenotype and the migration and invasion capabilities of these cells. These results indicate that SCP1 is the phosphatase that counterregulates the MAPK-mediated phosphorylation of Ser(68)-Twist1. Thus, an increase in SCP1 expression and activity may be a useful strategy for eliminating the detrimental roles of Twist1 in cancer cells.

Citing Articles

Retinoic acid induced specific changes in the phosphoproteome of C17.2 neural stem cells.

Zhang C, Ge L, Xie H, Liu X, Xun C, Chen Y J Cell Mol Med. 2024; 28(7):e18205.

PMID: 38506089 PMC: 10951872. DOI: 10.1111/jcmm.18205.

Molecular mechanisms of TWIST1-regulated transcription in EMT and cancer metastasis.

Yu X, He T, Tong Z, Liao L, Huang S, Fakhouri W EMBO Rep. 2023; 24(11):e56902.

PMID: 37680145 PMC: 10626429. DOI: 10.15252/embr.202356902.

Tumor Suppressor Properties of Small C-Terminal Domain Phosphatases in Clear Cell Renal Cell Carcinoma.

Krasnov G, Puzanov G, Dashinimaev E, Vishnyakova K, Kondratieva T, Chegodaev Y Int J Mol Sci. 2023; 24(16).

PMID: 37629167 PMC: 10455398. DOI: 10.3390/ijms241612986.

Investigation of Flavonoid Scaffolds as DAX1 Inhibitors against Ewing Sarcoma through Pharmacoinformatic and Dynamic Simulation Studies.

Yasir M, Park J, Han E, Park W, Han J, Kwon Y Int J Mol Sci. 2023; 24(11).

PMID: 37298283 PMC: 10253386. DOI: 10.3390/ijms24119332.

MiR-574-5p promotes cell proliferation by negatively regulating small C-terminal domain phosphatase 1 in esophageal squamous cell carcinoma.

Zhao C, Liu J, Xu Y, Guo J, Wang L, Chen L Iran J Basic Med Sci. 2022; 25(10):1243-1250.

PMID: 36311195 PMC: 9588319. DOI: 10.22038/IJBMS.2022.65886.14492.

References

Lin X, Duan X, Liang Y, Su Y, Wrighton K, Long J . PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell. 2006; 125(5):915-28. PMC: 6309366. DOI: 10.1016/j.cell.2006.03.044. View

Wrighton K, Willis D, Long J, Liu F, Lin X, Feng X . Small C-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance transforming growth factor-beta signaling. J Biol Chem. 2006; 281(50):38365-75. DOI: 10.1074/jbc.M607246200. View

Tamura S, Toriumi S, Saito J, Awano K, Kudo T, Kobayashi T . PP2C family members play key roles in regulation of cell survival and apoptosis. Cancer Sci. 2006; 97(7):563-7. PMC: 11159723. DOI: 10.1111/j.1349-7006.2006.00219.x. View

Yeo M, Lee S, Lee B, Ruiz E, Pfaff S, Gill G . Small CTD phosphatases function in silencing neuronal gene expression. Science. 2005; 307(5709):596-600. DOI: 10.1126/science.1100801. View

Weiss M, Abel E, Mayberry M, Basile K, Berger A, Aplin A . TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells. Cancer Res. 2012; 72(24):6382-92. PMC: 3531871. DOI: 10.1158/0008-5472.CAN-12-1033. View

Su Y, Xie T, Sano D, Myers J . IL-6 stabilizes Twist and enhances tumor cell motility in head and neck cancer cells through activation of casein kinase 2. PLoS One. 2011; 6(4):e19412. PMC: 3084854. DOI: 10.1371/journal.pone.0019412. View

Qin Q, Xu Y, He T, Qin C, Xu J . Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res. 2011; 22(1):90-106. PMC: 3351934. DOI: 10.1038/cr.2011.144. View

Eckert M, Lwin T, Chang A, Kim J, Danis E, Ohno-Machado L . Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell. 2011; 19(3):372-86. PMC: 3072410. DOI: 10.1016/j.ccr.2011.01.036. View

Banerjee A, Wu Z, Qian P, Kang J, Pandey V, Liu D . ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma. Breast Cancer Res. 2011; 13(6):R112. PMC: 3326554. DOI: 10.1186/bcr3054. View

10.

Vichalkovski A, Gresko E, Hess D, Restuccia D, Hemmings B . PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage. Oncogene. 2010; 29(24):3554-65. DOI: 10.1038/onc.2010.115. View

11.

Yang J, Mani S, Liu Donaher J, Ramaswamy S, Itzykson R, Come C . Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004; 117(7):927-39. DOI: 10.1016/j.cell.2004.06.006. View

12.

Janssens V, Goris J . Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J. 2001; 353(Pt 3):417-39. PMC: 1221586. DOI: 10.1042/0264-6021:3530417. View

13.

Mikheeva S, Mikheev A, Petit A, Beyer R, Oxford R, Khorasani L . TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer. 2010; 9:194. PMC: 2920263. DOI: 10.1186/1476-4598-9-194. View

14.

Fu J, Qin L, He T, Qin J, Hong J, Wong J . The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis. Cell Res. 2010; 21(2):275-89. PMC: 3193433. DOI: 10.1038/cr.2010.118. View

15.

Sacco F, Perfetto L, Castagnoli L, Cesareni G . The human phosphatase interactome: An intricate family portrait. FEBS Lett. 2012; 586(17):2732-9. PMC: 3437441. DOI: 10.1016/j.febslet.2012.05.008. View

16.

Moorhead G, Trinkle-Mulcahy L, Ulke-Lemee A . Emerging roles of nuclear protein phosphatases. Nat Rev Mol Cell Biol. 2007; 8(3):234-44. DOI: 10.1038/nrm2126. View

17.

Wang Y, Zhou B . Epithelial-mesenchymal Transition---A Hallmark of Breast Cancer Metastasis. Cancer Hallm. 2014; 1(1):38-49. PMC: 3944831. DOI: 10.1166/ch.2013.1004. View

18.

Lander R, Nasr T, Ochoa S, Nordin K, Prasad M, Labonne C . Interactions between Twist and other core epithelial-mesenchymal transition factors are controlled by GSK3-mediated phosphorylation. Nat Commun. 2013; 4:1542. PMC: 4198179. DOI: 10.1038/ncomms2543. View

19.

Yeo M, Lin P, Dahmus M, Gill G . A novel RNA polymerase II C-terminal domain phosphatase that preferentially dephosphorylates serine 5. J Biol Chem. 2003; 278(28):26078-85. DOI: 10.1074/jbc.M301791200. View

20.

Kim Y, Bahk Y . A study of substrate specificity for a CTD phosphatase, SCP1, by proteomic screening of binding partners. Biochem Biophys Res Commun. 2014; 448(2):189-94. DOI: 10.1016/j.bbrc.2014.04.089. View